BackTetraLogic Pharmaceuticals Overview

TetraLogic Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for TLOG.

Quarterly Other Income/Expense

-$9.52M
↓ 318.14% YoY

As of Sep 30, 2016

Annual Other Income/Expense (TTM)

-$15.44M
↓ 83.17% YoY

Trailing 12 months ending Sep 30, 2016

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin